Oxidative stress, inflammation and cardiovascular mortality in haemodialysis—role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-u
Background: Chronic kidney disease is a devastating disease with clinical and ethical dimensions and...
Copyright © 2014 Arif Showkat et al. This is an open access article distributed under the Creative C...
Background. Cardiovascular events (CVE) are a major cause of morbidity and mortality in end-stage re...
Oxidative stress, inflammation and cardiovascular mortality in haemodialysis—role of seniority and i...
Background. Increased oxidative stress (OS) and inflammation are associated with atherosclerotic cor...
Background. Cardiovascular disease (CVD) is com-mon in haemodialysis patients with chronic renal ins...
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies...
Background. Iron supplementation is a mainstay for management of renal anaemia in patients receiving...
Sir, Cardiovascular disease remains one of the leading causes of mortality in haemodialysis (HD) pat...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
Background. Patients receiving dialysis therapy for end-stage kidney failure have a high cardiovascu...
is available at the end of the articleBackground Infection is the leading cause of morbidity and the...
Copyright © 2013 Hadja Fatima Tbahriti et al. This is an open access article distributed under the C...
The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and ...
Background: Chronic kidney disease is a devastating disease with clinical and ethical dimensions and...
Copyright © 2014 Arif Showkat et al. This is an open access article distributed under the Creative C...
Background. Cardiovascular events (CVE) are a major cause of morbidity and mortality in end-stage re...
Oxidative stress, inflammation and cardiovascular mortality in haemodialysis—role of seniority and i...
Background. Increased oxidative stress (OS) and inflammation are associated with atherosclerotic cor...
Background. Cardiovascular disease (CVD) is com-mon in haemodialysis patients with chronic renal ins...
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies...
Background. Iron supplementation is a mainstay for management of renal anaemia in patients receiving...
Sir, Cardiovascular disease remains one of the leading causes of mortality in haemodialysis (HD) pat...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
Background. Patients receiving dialysis therapy for end-stage kidney failure have a high cardiovascu...
is available at the end of the articleBackground Infection is the leading cause of morbidity and the...
Copyright © 2013 Hadja Fatima Tbahriti et al. This is an open access article distributed under the C...
The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and ...
Background: Chronic kidney disease is a devastating disease with clinical and ethical dimensions and...
Copyright © 2014 Arif Showkat et al. This is an open access article distributed under the Creative C...
Background. Cardiovascular events (CVE) are a major cause of morbidity and mortality in end-stage re...